Recently, synthetic cannabinoids like AB-CHMINACA have captured the attention of equally the scientific community and leisure end users. This compound, noted for its potent psychoactive outcomes, is part of the broader class of artificial substances designed to mimic the effects of THC, the main psychoactive part in cannabis. Even so, compared with